<li>cholestyramine<p>cholestyramine decreases levels of ezetimibe by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Separate by 2-4 hours.</p></li><li>sofosbuvir/velpatasvir<p>sofosbuvir/velpatasvir increases levels of ezetimibe by Other (see comment). Use Caution/Monitor. 
Comment: Velpatasvir inhibits OATP1B1, OATP1B3, and OATP2B1 transporters. .</p></li>